The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
Open Access
- 1 April 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 17 (2) , e70065
Abstract
INTRODUCTION: Mild cognitive impairment (MCI) is common in older adults, but the burden on patients and health systems is not well understood. We aimed to estimate the impact of MCI on healthcare utilization and costs. METHODS: This was a matched cohort study in UK Biobank comparing healthcare costs and Alzheimer's disease (AD) dementia incidence rates in participants with MCI to propensity score‐matched participants without MCI. RESULTS: Of 164,508 eligible participants, 6605(4%) had cognitive testing scores consistent with MCI. Ten‐year inpatient costs were 7.6% higher in MCI versus matched no‐MCI participants, while 6‐year primary care costs were 9.1% higher. Among MCI participants, AD dementia incidence rates were substantially higher than in non‐MCI participants (7.2 5‐year incidence rate ratio 95% CI: 3.3 to 15.7), and eventual AD dementia accrued higher additional inpatient costs (mean £20,199) over 10 years. DISCUSSION: MCI is characterized by modestly higher healthcare utilization and costs. Subsequent AD dementia diagnosis was strongly associated with costs. Highlights: Baseline cognitive tests identified individuals with all‐cause MCI in the UK Biobank. We compared individuals with MCI to propensity score‐matched participants without MCI. Inpatient costs were 7.6% higher over 10 years, and primary care costs were 9.1% higher over 6 years for participants with MCI. AD dementia incidence rate ratio was 7.2 higher in participants with MCI. Among MCI participants, eventual AD dementia was a key driver of costs resulting in higher inpatient costs (mean £20,199) over 10 years.Keywords
Funding Information
- Novo Nordisk
This publication has 37 references indexed in Scilit:
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Mild Cognitive ImpairmentArchives of Neurology, 2009
- Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studiesActa Psychiatrica Scandinavica, 2009
- Direct costs associated with mild cognitive impairment in primary careInternational Journal of Geriatric Psychiatry, 2008
- Prevalence and Persistence of Mild Cognitive Impairment among Elderly Patients in General HospitalsDementia and Geriatric Cognitive Disorders, 2006
- Pharmacoeconomics of mild cognitive impairmentActa Neurologica Scandinavica, 2003
- Costing hospital activity: the experience with healthcare resource groups in EnglandThe European Journal of Health Economics, 2002